Quick Takeaways
- ADAR1 Capital Management, LLC filed SCHEDULE 13G for Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (SPRB).
- Disclosed ownership: 5.4%.
- Date of event: 31 Dec 2025.
ADAR1 Capital Management, LLC - 31 Dec 2025 SCHEDULE 13G Report for Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (SPRB)
- Filing Manager
- ADAR1 Capital Management, LLC
- Reporting Manager
- ADAR1 Capital Management, LLC
- Symbol
- SPRB
- Shares outstanding
- 1,074,074 shares
- Disclosed Ownership
- 58,000 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 20:16:42 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ADAR1 Capital Management, LLC disclosed 5.4% ownership in Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (SPRB) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 20:16.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 5.4% | 58,000 | 0 | 58,000 | /s/ Daniel Schneeberger | Daniel Schneeberger, Manager | |
| Daniel Schneeberger | 5.4% | 58,000 | 0 | 58,000 | /s/ Daniel Schneeberger | Daniel Schneeberger, in his individual capacity |